AAAAAA
Results: 1-25/57
Authors:
SHARPE N
Citation: N. Sharpe, TOWARDS 2001 - WILL ACE-INHIBITORS HAVE A ROLE IN ATHEROSCLEROSIS TREATMENT, International journal of clinical practice, 1998, pp. 26-31
Authors:
WHALLEY GA
GAMBLE GD
DOUGHTY RN
MACMAHON S
SHARPE N
Citation: Ga. Whalley et al., SELECTION BIAS IN CLINICAL RESEARCH WHEN SUBJECTS ARE EXCLUDED BECAUSE OF FAILURE TO ESTIMATE LEFT-VENTRICULAR MASS BY ECHOCARDIOGRAPHY, Journal of the American Society of Echocardiography, 11(11), 1998, pp. 1050-1055
Authors:
GAMBLE G
MACMAHON S
CULPAN A
CIOBO C
WHALLEY G
SHARPE N
Citation: G. Gamble et al., ATHEROSCLEROSIS AND LEFT-VENTRICULAR HYPERTROPHY - PERSISTING PROBLEMS IN TREATED HYPERTENSIVE PATIENTS, Journal of hypertension, 16(9), 1998, pp. 1389-1395
Authors:
MACMAHON S
SHARPE N
GAMBLE G
CIOBO C
CLAGUE A
FLETT S
WHALLEY G
HART H
SCOTT J
WHITE H
Citation: S. Macmahon et al., EFFECTS OF RAMIPRIL ON CAROTID ATHEROSCLEROSIS IN PATIENTS AT HIGH-RISK OF CARDIOVASCULAR EVENTS - RESULTS FROM THE PART-2 TRIAL, Journal of hypertension, 16, 1998, pp. 165-165
Authors:
SHARPE N
DOUGHTY RN
Citation: N. Sharpe et Rn. Doughty, LEFT-VENTRICULAR REMODELING AND IMPROVED LONG-TERM OUTCOMES IN CHRONIC HEART-FAILURE, European heart journal, 19, 1998, pp. 36-39
Authors:
SHARPE N
Citation: N. Sharpe, HEART-FAILURE MANAGEMENT - A BROADER VIEW REQUIRED, European heart journal, 19(7), 1998, pp. 975-975
Authors:
SHARPE N
Citation: N. Sharpe, HEART-FAILURE IN THE COMMUNITY, Progress in cardiovascular diseases, 41(1), 1998, pp. 73-76
Authors:
TONKIN A
AYLWARD P
COLQUHOUN D
GLASZIOU P
HARRIS P
MACMAHON S
MAGNUS P
NEWEL D
NESTEL P
SHARPE N
HUNT D
SHAW J
SIMES RJ
THOMPSON P
THOMSON A
WEST M
WHITE H
SIMES S
HAGUE W
CALEO S
HALL J
MARTIN A
MULRAY S
BARTER P
BEILIN L
COLLINS R
MCNEIL J
MEIER P
WILLIMOTT H
SMITHERS D
WALLACE P
SULLIVAN D
KEECH A
Citation: A. Tonkin et al., PREVENTION OF CARDIOVASCULAR EVENTS AND DEATH WITH PRAVASTATIN IN PATIENTS WITH CORONARY HEART-DISEASE AND A BROAD RANGE OF INITIAL CHOLESTEROL LEVELS, The New England journal of medicine, 339(19), 1998, pp. 1349-1357
Authors:
SHARPE N
Citation: N. Sharpe, EPROSARTAN - A VIEWPOINT, Drugs, 55(5), 1998, pp. 719-720
Authors:
PALMIERI V
BELLA JN
HAHN RT
PARANICAS M
FISHMAN D
DEQUATTRO V
SHARPE N
DESIMONE G
DAHLOF B
Citation: V. Palmieri et al., INTRAINDIVIDUAL RELIABILITY OF ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR MASS AND GEOMETRY - THE PRESERVE TRIAL, Circulation, 98(17), 1998, pp. 142-142
Authors:
DEVEREUX RB
PALMIERI V
BELLA JN
DEQUATTRO V
SHARPE N
DESIMONE G
DAHLOF B
Citation: Rb. Devereux et al., IMPACT OF ANTIHYPERTENSIVE THERAPY ON LEFT-VENTRICULAR MASS, GEOMETRYAND HEMODYNAMICS IN PATIENTS WITH LEFT-VENTRICULAR HYPERTROPHY - THE PRESERVE TRIAL, Circulation, 98(17), 1998, pp. 143-143
Authors:
RICHARDS AM
DOUGHTY R
NICHOLLS MG
MACMAHON S
IKRAM H
SHARPE N
ESPINER EA
FRAMPTON C
YANDLE TG
Citation: Am. Richards et al., NEUROHUMORAL PREDICTION OF BENEFIT FROM CARVEDILOL IN ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION, Circulation, 98(17), 1998, pp. 350-350
Authors:
MACMAHON S
SHARPE N
GAMBLE G
HART H
SCOTT J
SIMES J
WHITE H
Citation: S. Macmahon et al., EFFECTS OF LOWERING AVERAGE OR BELOW-AVERAGE CHOLESTEROL LEVELS ON THE PROGRESSION OF CAROTID ATHEROSCLEROSIS - RESULTS OF THE LIPID ATHEROSCLEROSIS SUBSTUDY (VOL 97, PG 1784, 1998), Circulation, 97(24), 1998, pp. 2479-2479
Authors:
MACMAHON S
SHARPE N
GAMBLE G
HART H
SCOTT J
SIMES J
WHITE H
Citation: S. Macmahon et al., EFFECTS OF LOWERING AVERAGE OR BELOW-AVERAGE CHOLESTEROL LEVELS ON THE PROGRESSION OF CAROTID ATHEROSCLEROSIS - RESULTS OF THE LIPID ATHEROSCLEROSIS SUBSTUDY, Circulation, 97(18), 1998, pp. 1784-1790
Authors:
DOUGHTY R
ANDERSEN V
SHARPE N
Citation: R. Doughty et al., OPTIMAL TREATMENT OF HEART-FAILURE IN THE ELDERLY, Drugs & aging, 10(6), 1997, pp. 435-443
Authors:
ROBSON R
COLLINS J
JOHNSON R
KITCHING R
SEARLE M
WALKER R
DOUGLAS J
LEARY J
WHALLEY G
SHARPE N
MACMAHON S
Citation: R. Robson et al., EFFECTS OF SIMVASTATIN AND ENALAPRIL ON SERUM-LIPOPROTEIN CONCENTRATIONS AND LEFT-VENTRICULAR MASS IN PATIENTS ON DIALYSIS, JN. Journal of nephrology, 10(1), 1997, pp. 33-40
Authors:
BAGG W
DOUGHTY RN
WHALLEY GA
GORDON G
SHARPE N
Citation: W. Bagg et al., INVESTIGATION OF LEFT-VENTRICULAR DYSFUNCTION IN ACUTE DYSPNEA - ECHOCARDIOGRAPHY IS IMPORTANT IN THE MANAGEMENT OF HEART-FAILURE, BMJ. British medical journal, 315(7108), 1997, pp. 604-605
Authors:
DOUGHTY RN
WHALLEY GA
GAMBLE G
MACMAHON S
SHARPE N
KRUM H
MURRAY Y
TONKIN A
TROTTER A
BURTON R
GARRETT J
LANE G
WATTS J
GEDDES C
HALL C
STEPHENSEN J
WOODHOUSE S
DAVIDSON T
BRADBURY J
HAMER A
HOPKINS L
JACKSON D
CROSS D
MORELAND F
HAWTIN B
KIMBER V
SAUNDERS M
THOMSON A
COLQUHOUN D
GOLDSMITH J
HICKS B
BOND C
FLETT S
MURPHY J
BRUNING J
JELLYMAN T
NAIRN L
BARTRAM H
MCCULLOCH A
MILNE A
PRASAD R
Citation: Rn. Doughty et al., LEFT-VENTRICULAR REMODELING WITH CARVEDILOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE DUE TO ISCHEMIC-HEART-DISEASE, Journal of the American College of Cardiology, 29(5), 1997, pp. 1060-1066
Authors:
DOUGHTY RN
WHALLEY G
GAMBLE G
MACMAHON S
SHARPE N
Citation: Rn. Doughty et al., CARVEDILOL IMPROVES LEFT-VENTRICULAR REGIONAL WALL-MOTION IN PATIENTSWITH HEART-FAILURE OF ISCHEMIC ETIOLOGY, Journal of the American College of Cardiology, 29(2), 1997, pp. 7274-7274
Authors:
DOUGHTY RN
RODGERS A
SHARPE N
MACMAHON S
Citation: Rn. Doughty et al., EFFECTS OF BETA-BLOCKER THERAPY ON MORTALITY IN PATIENTS WITH HEART-FAILURE - A SYSTEMATIC OVERVIEW OF RANDOMIZED CONTROLLED TRIALS, European heart journal, 18(4), 1997, pp. 560-565
Authors:
SHARPE N
Citation: N. Sharpe, MEASURING FATALITY RATES FROM MYOCARDIAL-INFARCTION, European heart journal, 18(1), 1997, pp. 9-11
Authors:
MACMAHON S
SHARPE N
DOUGHTY R
KRUM H
TONKIN A
TROTTER A
BURTON R
GARRETT J
LANE G
OWENSBY D
RYAN J
SHEPHERD J
SINGH B
JACKSON B
RUDGE G
STEPHENSEN J
WOODHOUSE S
DAVIDSON P
TURNER J
WALSH W
BRADBURY J
HAMER A
CROSS D
HALL C
KIMBER V
SPAULDING C
THOMPSON PL
HOROWITZ J
LESLIE S
ZHANG Y
COLQUHOUN D
HICKS B
JEFFERY I
TAVERNER P
BOND C
MURPHY J
IKRAM H
RICHARDS M
LOW C
SCOTT D
BROWN G
LEWIS G
BRUNING J
NAIRN L
CLAYTON A
CRAWFORD J
MCALISTER H
BARTRAM H
MCCULLOCH A
MILNE A
PRASAD R
YEE T
WHALLEY G
REID I
Citation: S. Macmahon et al., RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CARVEDILOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE DUE TO ISCHEMIC-HEART-DISEASE, Lancet, 349(9049), 1997, pp. 375-380
Authors:
DOUGHTY RN
SHARPE N
Citation: Rn. Doughty et N. Sharpe, BETA-ADRENERGIC BLOCKING-AGENTS IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE - MECHANISMS AND CLINICAL-RESULTS, Annual review of medicine, 48, 1997, pp. 103-114
Authors:
KRUM H
SHUSTERMAN N
MACMAHON S
SHARPE N
Citation: H. Krum et al., SAFETY OF CARVEDILOL IN PATIENTS WITH CHRONIC HEART-FAILURE RECEIVINGCONCOMITANT AMIODARONE THERAPY, Circulation, 96(8), 1997, pp. 3233-3233
Authors:
HILL AA
PLANK LD
FINN PJ
WHALLEY GA
SHARPE N
CLARK MA
HILL GL
Citation: Aa. Hill et al., MASSIVE NITROGEN LOSS IN CRITICAL SURGICAL ILLNESS - EFFECT ON CARDIAC MASS AND FUNCTION, Annals of surgery, 226(2), 1997, pp. 191-197